“CARDIOVASCULAR RISK FEATURES IN PATIENTS WITH METABOLIC-ASSOCIATED FATTY LIVER DISEASE (MAFLD) DEPENDING ON THE PRESENCE OF OBESITY”. 2025. International Journal of Medical Sciences 5 (05): 396-403. https://doi.org/10.55640/.